These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12657277)

  • 41. Translocational status of ApoB in the presence of an inhibitor of microsomal triglyceride transfer protein.
    Macri J; Kazemian P; Kulinski A; Rudy D; Aiton A; Thibert RJ; Adeli K
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1035-47. PubMed ID: 11027587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mitochondrial triglyceride transfer protein inhibition: new achievements in the treatment of dyslipidemias.
    Kostapanos MS; Rizos EC; Papanas N; Maltezos E; Elisaf MS
    Curr Pharm Des; 2013; 19(17):3150-60. PubMed ID: 23317403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potential antifertility agents. 7. Synthesis and biological activities of 2-,3-, and 6-alkyl-substituted 4-aryl-2-methylcyclohexanecarboxylic acids.
    Crenshaw RR; Luke GM; Jenks TA; Bialy G
    J Med Chem; 1974 Dec; 17(12):1262-8. PubMed ID: 4372352
    [No Abstract]   [Full Text] [Related]  

  • 44. Thiomorpholine Derivatives with Hypolipidemic and Antioxidant Activity.
    Tooulia KK; Theodosis-Nobelos P; Rekka EA
    Arch Pharm (Weinheim); 2015 Sep; 348(9):629-34. PubMed ID: 26191791
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 2-Azetidinone cholesterol absorption inhibitors: structure-activity relationships on the heterocyclic nucleus.
    Clader JW; Burnett DA; Caplen MA; Domalski MS; Dugar S; Vaccaro W; Sher R; Browne ME; Zhao H; Burrier RE; Salisbury B; Davis HR
    J Med Chem; 1996 Sep; 39(19):3684-93. PubMed ID: 8809157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of hamster hepatic microsomal triglyceride transfer protein mRNA levels by dietary fats.
    Bennett AJ; Billett MA; Salter AM; White DA
    Biochem Biophys Res Commun; 1995 Jul; 212(2):473-8. PubMed ID: 7626061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport.
    Tchoua U; D'Souza W; Mukhamedova N; Blum D; Niesor E; Mizrahi J; Maugeais C; Sviridov D
    Cardiovasc Res; 2008 Mar; 77(4):732-9. PubMed ID: 18056760
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel acyl-CoA:cholesterol acyltransferase inhibitors. Synthesis and biological activity of 3-quinolylurea derivatives.
    Tawada H; Harcourt M; Kawamura N; Kajino M; Ishikawa E; Sugiyama Y; Ikeda H; Meguro K
    J Med Chem; 1994 Jun; 37(13):2079-84. PubMed ID: 8027989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investigational therapies for the treatment of atherosclerosis.
    Tomkin GH; Owens D
    Expert Opin Investig Drugs; 2014 Oct; 23(10):1411-21. PubMed ID: 24857672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4 -hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorption.
    Rosenblum SB; Huynh T; Afonso A; Davis HR; Yumibe N; Clader JW; Burnett DA
    J Med Chem; 1998 Mar; 41(6):973-80. PubMed ID: 9526571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acyl CoA:cholesterol acyltransferase (ACAT) inhibitors: synthesis and structure-activity relationship studies of a new series of trisubstituted imidazoles.
    Higley CA; Wilde RG; Maduskuie TP; Johnson AL; Pennev P; Billheimer JT; Robinson CS; Gillies PJ; Wexler RR
    J Med Chem; 1994 Oct; 37(21):3511-22. PubMed ID: 7932580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Triphenylethanamine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors: Discovery of N-[(1R)-1-(3-Cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide (BMS-795311).
    Qiao JX; Wang TC; Adam LP; Chen AY; Taylor DS; Yang RZ; Zhuang S; Sleph PG; Li JP; Li D; Yin X; Chang M; Chen XQ; Shen H; Li J; Smith D; Wu DR; Leith L; Harikrishnan LS; Kamau MG; Miller MM; Bilder D; Rampulla R; Li YX; Xu C; Lawrence RM; Poss MA; Levesque P; Gordon DA; Huang CS; Finlay HJ; Wexler RR; Salvati ME
    J Med Chem; 2015 Nov; 58(22):9010-26. PubMed ID: 26524347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of atrop fixed alkoxy-aminobenzhydrol derivatives: novel, highly potent and orally efficacious squalene synthase inhibitors.
    Ichikawa M; Yokomizo A; Itoh M; Haginoya N; Sugita K; Usui H; Terayama K; Kanda A
    Bioorg Med Chem; 2011 Sep; 19(17):5207-24. PubMed ID: 21802309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and activity of a novel series of 3-biarylquinuclidine squalene synthase inhibitors.
    Brown GR; Clarke DS; Foubister AJ; Freeman S; Harrison PJ; Johnson MC; Mallion KB; McCormick J; McTaggart F; Reid AC; Smith GJ; Taylor MJ
    J Med Chem; 1996 Jul; 39(15):2971-9. PubMed ID: 8709131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of a simple picomolar inhibitor of cholesteryl ester transfer protein.
    Reinhard EJ; Wang JL; Durley RC; Fobian YM; Grapperhaus ML; Hickory BS; Massa MA; Norton MB; Promo MA; Tollefson MB; Vernier WF; Connolly DT; Witherbee BJ; Melton MA; Regina KJ; Smith ME; Sikorski JA
    J Med Chem; 2003 May; 46(11):2152-68. PubMed ID: 12747787
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microsomal transfer protein (MTP) inhibition-a novel approach to the treatment of homozygous hypercholesterolemia.
    Sirtori CR; Pavanello C; Bertolini S
    Ann Med; 2014 Nov; 46(7):464-74. PubMed ID: 24987866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and hypocholesterolemic activity of 6,7-dihydro-4H-pyrazolo[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-diones, novel inhibitors of acylCoA:cholesterol O-acyltransferase.
    Larsen SD; Spilman CH; Bell FP; Dinh DM; Martinborough E; Wilson GJ
    J Med Chem; 1991 May; 34(5):1721-7. PubMed ID: 2033594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Azalanstat (RS-21607), a lanosterol 14 alpha-demethylase inhibitor with cholesterol-lowering activity.
    Burton PM; Swinney DC; Heller R; Dunlap B; Chiou M; Malonzo E; Haller J; Walker KA; Salari A; Murakami S
    Biochem Pharmacol; 1995 Aug; 50(4):529-44. PubMed ID: 7646560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alkyl lysophosphatidic acid and fluoromethylene phosphonate analogs as metabolically-stabilized agonists for LPA receptors.
    Xu Y; Tanaka M; Arai H; Aoki J; Prestwich GD
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5323-8. PubMed ID: 15454220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design and synthesis of potent, selective inhibitors of endothelin-converting enzyme.
    Wallace EM; Moliterni JA; Moskal MA; Neubert AD; Marcopulos N; Stamford LB; Trapani AJ; Savage P; Chou M; Jeng AY
    J Med Chem; 1998 Apr; 41(9):1513-23. PubMed ID: 9554884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.